| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 217.69B | 221.64B | 225.78B | 235.86B | 225.08B | 209.71B |
| Gross Profit | 39.59B | 50.69B | 48.29B | 51.78B | 51.42B | 38.15B |
| EBITDA | 33.25B | 36.49B | 35.06B | 38.12B | 38.47B | 29.95B |
| Net Income | 9.31B | 11.59B | 12.24B | 14.64B | 14.32B | 5.69B |
Balance Sheet | ||||||
| Total Assets | 215.43B | 215.44B | 236.04B | 226.63B | 225.34B | 220.07B |
| Cash, Cash Equivalents and Short-Term Investments | 48.54B | 52.87B | 68.30B | 63.02B | 65.56B | 70.09B |
| Total Debt | 35.50B | 37.41B | 65.01B | 10.29B | 17.66B | 24.89B |
| Total Liabilities | 82.40B | 81.75B | 109.23B | 55.34B | 67.45B | 78.00B |
| Stockholders Equity | 133.03B | 133.70B | 126.81B | 171.28B | 157.89B | 142.06B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 18.29B | 14.49B | 9.88B | 5.47B | 10.93B |
| Operating Cash Flow | 0.00 | 36.34B | 34.86B | 32.45B | 24.43B | 29.11B |
| Investing Cash Flow | 0.00 | -19.20B | -20.31B | -23.43B | -20.29B | -18.80B |
| Financing Cash Flow | 0.00 | -31.57B | -11.90B | -11.64B | -9.98B | 15.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥439.01B | 9.21 | 11.96% | 3.04% | 2.70% | ― | |
78 Outperform | ¥716.10B | 15.50 | 8.07% | 2.85% | 11.18% | -0.75% | |
74 Outperform | ¥6.87T | 59.16 | 8.95% | 1.88% | 2.88% | 28.76% | |
67 Neutral | ¥3.98T | 15.03 | ― | 1.41% | 7.73% | -1.93% | |
64 Neutral | ¥161.39B | 29.59 | 5.91% | 2.39% | -3.24% | -25.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | ¥886.92B | 36.79 | 2.99% | 2.62% | 3.51% | ― |